CPT® Code 0239T

Deleted

Bioimpedance spectroscopy (BIS), measuring 100 frequencies or greater, direct measurement of extracellular fluid differences between the limbs

Bioimpedance spectroscopy (BIS) is an advanced diagnostic technology utilized primarily for the early detection and management of lymphedema, particularly in patients who have undergone mastectomy or pelvic surgery due to malignancies. This innovative method is capable of identifying variations in extracellular fluid levels between different limbs, often before any visible swelling occurs or before the patient experiences symptoms typically associated with early lymphedema. Although lymphedema itself cannot be entirely prevented, the ability to diagnose it at an early stage enables healthcare providers to initiate appropriate therapeutic interventions aimed at mitigating the negative consequences associated with this condition. The BIS technique employs a non-invasive approach by applying a low-level electric current to the body, which measures the resistance encountered as the current passes through various tissues. This resistance, or impedance, is then analyzed to determine the differences in extracellular fluid volumes between the limbs. For the assessment of fluid levels in the upper extremities, two electrodes are strategically placed on each hand, along with a set on one foot. Conversely, when evaluating the lower extremities, electrodes are positioned on each foot and one hand. Once the BIS device is activated, it captures the extracellular fluid measurements from each limb, allowing for a comparative analysis of impedance values. The physician subsequently reviews these measurements in conjunction with any prior BIS data to ascertain whether the findings suggest the presence of early lymphedema, thereby facilitating timely and effective treatment options to alleviate the potential adverse effects of this condition.